Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SI | P14410 | 2/20 | 0.54 |
| ▸ | FUCA1 | P04066 | 12/20 | 0.46 |
| ▸ | GBA1 | P04062 | 2/20 | 0.45 |
| ▸ | MGAM | O43451 | 1/20 | 0.44 |
| ▸ | OGA | O60502 | 2/20 | 0.39 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.36 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15627029 | 1.00 | SI (0.54) | SIFUCA1GBA1MGAMOGA | |
| SCHEMBL13424357 | 1.00 | SI (0.54) | SIFUCA1GBA1MGAMOGA | |
| SCHEMBL12879434 | 1.00 | SI (0.54) | SIFUCA1GBA1MGAMOGA | |
| SCHEMBL12863707 | 1.00 | SI (0.54) | SIFUCA1GBA1MGAMOGA | |
| SCHEMBL13455839 | 1.00 | SI (0.54) | SIFUCA1GBA1MGAMOGA | |
| SCHEMBL12910796 | 1.00 | SI (0.54) | SIFUCA1GBA1MGAMOGA | |
| SCHEMBL13424330 | 1.00 | SI (0.54) | SIFUCA1GBA1MGAMOGA | |
| SCHEMBL25721071 | 1.00 | SI (0.54) | SIFUCA1GBA1MGAMOGA | |
| SCHEMBL15627023 | 1.00 | SI (0.54) | SIFUCA1GBA1MGAMOGA | |
| SCHEMBL13455838 | 1.00 | SI (0.54) | SIFUCA1GBA1MGAMOGA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160045611-A1 | SUGAR-LINKER-DRUG CONJUGATES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160045611-A1 | SUGAR-LINKER-DRUG CONJUGATES | FUT5, FUT6, B3GNT2 | SI 30/4885FUCA1 764/4885GBA1 489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.